Dalian, China (PressExposure) February 02, 2010 -- NeuroTalk-2010 Theme: From Nervous Functions to Treatment Time: June 25-28, 2010 Venue: Singapore Expo, Singapore Website: http://www.bit-neurotalk.com

BIT is honored to welcome you to attend the 1st Annual World Congress of NeuroTalk (NeuroTalk-2010) which will be held at Singapore Expo, Singapore during June 25-28, 2010. It is a dedicated event for global neuroscientists with a theme of "From Nervous Functions to Treatment". The meeting is designed to provide a strong platform for professionals from both academic and industrial sections to make experience exchanges around the world.

Neurologists, neuropathologists, neurosurgeons, neurooncologists, neuroscientists and pioneers in Neurosciences R&D will be invited locally and globally to speak on a variety of topics including basic neuroscience, CNS, Neurodegenerative Diseases, Drug Discovery, novel technology and device for Diagnostics and Therapeutics, and Business Development in Neuroscience Industries. Target participants include local and overseas medical professionals and delegates from leading biopharmaceutical companies across the world.

NeuroTalk-2010 consists of 6 main tracks, panel discussions, free communications, poster presentations, and Exhibition booths that will cover all the main neurological aspects and will give you the opportunity to be updated in all the sectors in neurological sciences.

Theme: From Nervous Functions to Treatment June 25-28, 2010 Singapore EXPO, Singapore http://www.bitlifesciences.com/neurotalk2010/default.asp BIT's 1st Annual World Congress of NeuroTalk-2010 For Press and Media Ms. April Wang BIT Life Sciences, Inc http://www.biteomics.com Singapore EXPO, Singapore 26 Gaoneng St., R405, Dalian Hightech Zone Dalian, LN 116025, China Tel: 0086-411-84795469 Fax: 0086-411-84799629 Email: april@bitlifesciences.com

About BIT

Dalian Biteomics, Inc. is a high-tech biological company established by overseas Chinese scientists, specializing in integration of current Chinese and overseas social and technological resources, providing frontier technologies and product services for human health and biological careers. Now the business of our company covers drug discovery, peptide synthesis, distribution of biological enzyme, and international business consultation and services

Press Release Source: http://PressExposure.com/PR/BIT.html